Cassava and former executives were charged Thursday by the SEC with making misleading claims in 2020 about trials for the ...

The Securities and Exchange Commission alleged that a researcher for the company manipulated trial data to make its drug ...

WASHINGTON (Reuters) -Shares of Cassava Sciences fell 10% in post-market trading on Thursday after the U.S. Securities and ...

Drugmaker Cassava Sciences Inc. and two former executives agreed to pay more than $40 million to resolve US Securities and ...

Cassava Sciences and two former executives will pay more than $40 million to settle charges related to misleading statements made about a clinical trial for the company's purported therapeutic ...

Shares of Cassava Sciences Inc. dropped more than 10% in the extended session Thursday after announcing a settlement with U.S ...

AUSTIN, Texas, Sept. 26, 2024 (GLOBE NEWSWIRE) -- (“Cassava” or the “Company”) (Nasdaq: SAVA), a biotechnology company ...

The U.S. Securities and Exchange Commission said on Thursday that it charged Cassava Sciences and two of the company's former ...

30, while Smartmatic has a separate suit pending against Fox News. Cassava Sciences settles SEC charges of 'misleading' Alzheimer's trial claims Shares of Cassava Sciences Inc. dropped more than 10% ...

After a third review of safety data, an independent board recommended two trials of simufilam for Alzheimer's continue ...

Germany's Vitesco Technologies will pay former parent Continental 125 million euros ($139.34 million) as part of an agreement ...

Italy's Tod's has appointed former Chanel executive John Galantic as CEO, taking over from the group's founder and chairman ...